Securities code: 002020 securities abbreviation: Zhejiang Jingxin Pharmaceutical Co.Ltd(002020) Announcement No.: 2021071 Zhejiang Jingxin Pharmaceutical Co.Ltd(002020)
Announcement of resolutions of the 20th meeting of the 7th board of supervisors
The company and all members of the board of supervisors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Zhejiang Jingxin Pharmaceutical Co.Ltd(002020) (hereinafter referred to as “the company”), the notice of the 20th meeting of the seventh board of supervisors was sent by e-mail on December 8, 2021, and the meeting was held in the conference room on the first floor of the company’s administrative building on December 14, 2021. The meeting should be attended by 3 supervisors, but there are actually 3 supervisors, which is in line with the company law and the articles of association Relevant provisions of the. The meeting was presided over by Hu Tianqing, chairman of the board of supervisors. The meeting reviewed and unanimously adopted the following resolutions:
1. The proposal on the acquisition of 100% equity and related party transactions of Guangdong Shaxi Pharmaceutical Co., Ltd. was reviewed and approved with 3 affirmative votes, 0 negative votes and 0 abstention.
The board of supervisors believes that the company and its related party xinchangyuanjin health industry investment partnership (limited partnership) and Jingxin Holding Group Co., Ltd. acquired equity related party transactions are necessary for the company’s business integration and sustainable operation and development. The pricing policies and basis of related party transactions are fair and reasonable, and there is no damage to the interests of the company and minority shareholders. During the deliberation of the board of directors, related directors also avoided voting, and the approval procedures did not violate relevant national laws and regulations And comply with the requirements of relevant laws and regulations and the articles of association.
It is hereby announced.
Zhejiang Jingxin Pharmaceutical Co.Ltd(002020) board of supervisors December 15, 2021
